Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles

Drug Development and Industrial Pharmacy

Volumn 39, Issue 2, 2013, Pages 164-175

  Shastri, Prathap Nagaraja ^a   Ubale, Ruhi V ^a   D'Souza, Martin J ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

Design of experiments; in vitro release; Microparticles; Oral route; Spray drying

Indexed keywords

BOVINE SERUM ALBUMIN; CHITOSAN; DRUG VEHICLE; EUDRAGIT; EUDRAGIT FS30D; EUDRAGIT L100 55; HYDROXYPROPYLMETHYLCELLULOSE; UNCLASSIFIED DRUG;

ARTICLE; COMPUTER PROGRAM; DRUG DESIGN; DRUG FORMULATION; ENTERIC COATED TABLET; PH; PROTEIN CONTENT; PROTEIN SECRETION; STOMACH PROTECTION; SUSTAINED DRUG RELEASE;

ACRYLIC RESINS; ALBUMINS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; MICROSPHERES; PARTICLE SIZE; POLYMETHACRYLIC ACIDS; SOLUBILITY;

EID: 84872011799     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.664148     Document Type: Article

References (31)

1. Sato AK, Viswanathan M, Kent RB, Wood CR. (2006). Therapeutic peptides: technological advances driving peptides into development. Curr Opin Biotechnol, 17:638-642. (Pubitemid 44791908)
2. Kim YJ, Doyle ML. (2010). Structural mass spectrometry in protein therapeutics discovery. Anal Chem, 82:7083-7089.
3. Cleland JL, Daugherty A, Mrsny R. (2001). Emerging protein delivery methods. Curr Opin Biotechnol, 12:212-219. (Pubitemid 32247411)
4. Brown LR. (2005). Commercial challenges of protein drug delivery. Expert Opin Drug Deliv, 2:29-42. (Pubitemid 40123881)
5. Shalaby WS. (1995). Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies. Clin Immunol Immunopathol, 74:127-134.
6. Uddin AN, Bejugam NK, Gayakwad SG, Akther P, D'Souza MJ. (2009). Oral delivery of gastro-resistant microencapsulated typhoid vaccine. J Drug Target, 17:553-560.
7. Goldberg M, Gomez-Orellana I. (2003). Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov, 2:289-295. (Pubitemid 37361687)
8. Carino GP, Mathiowitz E. (1999). Oral insulin delivery. Adv Drug Deliv Rev, 35:249-257. (Pubitemid 29073617)
9. Jain D, Panda AK, Majumdar DK. (2005). Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech, 6:E100-E107. (Pubitemid 41644139)
10. Nafissi-Varcheh N, Erfan M, Aboofazeli R. (2008). An approach to the design of a particulate system for oral protein delivery. I. In vitro stability of various poly (alpha-hydroxy acids)-microspheres in simulated gastrointestinal fluids. J Microencapsul, 25:584-592.
11. Jeffrey L. Cleland RL. 1994. Formulation and delivery of proteins and peptides, Acs Symposium Series.
12. Raymond T, Bartus, M. A. T., Dwaine F Emerich, and Stephen E. Zale 1998. Sustained delivery of proteins for novel therapeutic Products. Science. Highwire Press.
13. Fu K, Klibanov AM, Langer R. (2000). Protein stability in controlledrelease systems. Nat Biotechnol, 18:24-25.
14. Bejugam NK, Uddin AN, Gayakwad SG, D'Souza MJ. (2008). Formulation and evaluation of albumin microspheres and its enteric coating using a spray-dryer. J Microencapsul, 25:577-583.
15. Nazzal S, Nutan M, Palamakula A, Shah R, Zaghloul AA, Khan MA. (2002). Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm, 240:103-114. (Pubitemid 34607707)
16. Billon A, Bataille B, Cassanas G, Jacob M. (2000). Development of spray-dried acetaminophen microparticles using experimental designs. Int J Pharm, 203:159-168. (Pubitemid 30627636)
17. Rafat M, Cléroux CA, Fong WG, Baker AN, Leonard BC, O'Connor MD et al. (2010). PEG-PLA microparticles for encapsulation and delivery of Tat-EGFP to retinal cells. Biomaterials, 31:3414-3421.
18. Malzert-Fréon A, Hennequin D, Rault S. (2010). Partial least squares analysis and mixture design for the study of the influence of composition variables on lipidic nanoparticle characteristics. J Pharm Sci, 99:4603-4615.
19. Jain D, Majumdar DK, Panda AK. (2006). Insulin loaded eudragit L100 microspheres for oral delivery: preliminary in vitro studies. J Biomater Appl, 21:195-211. (Pubitemid 44848516)
20. Akhgari A, Farahmand F, Afrasiabi Garekani H, Sadeghi F, Vandamme TF. (2006). Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery. Eur J Pharm Sci, 28:307-314. (Pubitemid 43792438)
21. Lee DW, Hwang SJ, Park JB, Park HJ. (2003). Preparation and release characteristics of polymer-coated and blended alginate microspheres. J Microencapsul, 20:179-192. (Pubitemid 36240613)
22. Ishida M, Abe K, Hashizume M, Kawamura M. (2008). A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules. Int J Pharm, 359:46-52.
23. Mehuys E, Vervaet C, Remon JP. (2004). Hot-melt extruded ethylcellulose cylinders containing a HPMC-Gelucire core for sustained drug delivery. J Control Release, 94:273-280. (Pubitemid 38117139)
24. Abd El-Hameed MD, Kellaway IW. (1997). Preparation and in vitro characterisation of mucoadhesive polymeric microspheres as intranasal delivery systems. Eur J Pharmaceut Biopharmaceut, 44:7.
25. Putney SD, Burke PA. (1998). Improving protein therapeutics with sustained-release formulations. Nat Biotechnol, 16:153-157. (Pubitemid 128723585)
26. Lennart Eriksson EJ, Wikstrom C. (1998). Mixture design-design generation, Pls analysis, and model usage. Chemometrics and Intelligent Laboratory Systems, 43: 24.
27. Makhlof A, Werle M, Tozuka Y, Takeuchi H. (2010). Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin. Int J Pharm, 397: 92-95.
28. Martin L, Wilson CG, Koosha F, Uchegbu IF. (2003). Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Eur J Pharm Biopharm, 55:35-45. (Pubitemid 36120493)
29. Derakhshandeh K, Erfan M, Dadashzadeh S. (2007). Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics. Eur J Pharm Biopharm, 66:34-41. (Pubitemid 46412968)
30. Li S, Lin S, Daggy BP, Mirchandani HL, Chien YW. (2003). Effect of HPMC and Carbopol on the release and floating properties of Gastric Floating Drug Delivery System using factorial design. Int J Pharm, 253:13-22. (Pubitemid 36197827)
31. Martinello T, Kaneko TM, Velasco MV, Taqueda ME, Consiglieri VO. (2006). Optimization of poorly compactable drug tablets manufactured by direct compression using the mixture experimental design. Int J Pharm, 322:87-95. (Pubitemid 44339597)